Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-25-025198

Chief Financial Officer acquired 152,672 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Samuelson Doug Chief Financial Officer 2025-10-08 Grant or award +152,672 293,039 D: show line 1 in the form
Loading xslF345X05/ownership.xml…